Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CACNA1H | O95180 | 9/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21164621 | 0.84 | ALDH1A1 (0.63) | ALDH1A1L3MBTL1POLBCYP3A4GAA | |
| SCHEMBL4365559 | 0.79 | ALDH1A1 (0.94) | ALDH1A1L3MBTL1POLBCYP3A4GAA | |
| SCHEMBL20445509 | 0.76 | KMT2A (0.39) | ALDH1A1GAALMNASMN1; SMN2 | |
| SCHEMBL20290187 | 0.72 | EPHX1 (0.44) | ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL24250786 | 0.71 | HSD11B1 (0.41) | ALDH1A1L3MBTL1 | |
| SCHEMBL18177916 | 0.71 | ALDH1A1 (0.94) | ALDH1A1L3MBTL1POLBCYP3A4GAA | |
| SCHEMBL18809046 | 0.71 | ALDH1A1 (0.43) | ALDH1A1GAALMNASMN1; SMN2 | |
| SCHEMBL13577608 | 0.69 | EPHX1 (0.63) | ALDH1A1CYP3A4KDM4ESMN1; SMN2 | |
| SCHEMBL20147371 | 0.69 | SIGMAR1 (0.47) | ALDH1A1POLBCYP3A4GAACYP2C19 | |
| SCHEMBL23846112 | 0.69 | OPRK1 (0.61) | ALDH1A1POLBLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | NUTECH VENTURES (US) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | FASN, LIPC, SREBF2 | ALDH1A1 1121/4885L3MBTL1 2703/4885POLB 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.